What was Braskem's recurring EBITDA in Q1 2026, and what key factor drove this improvement?

Braskem's recurring EBITDA in Q1 2026 was $192 million, representing a 76% increase year-over-year, driven primarily by higher petrochemical utilization rates.

How did Braskem's regional operations perform in Q1 2026, and what supported the rebound?

Braskem's Brazilian and U.S./European operations both saw a rebound in Q1 2026, supported by normalized production and stronger spreads.

Braskem Posts Stronger 1Q26 EBITDA as Petrochemical Utilization Rebounds

May 14, 2026

Braskem reported a 76% surge in first-quarter 2026 EBITDA to $192 million, driven by rebounding petrochemical utilization rates globally. Despite negative operating cash flow, the company maintained a strong cash position while advancing its sustainable bio-based product portfolio.

TipRanks

Braskem Posts Stronger 1Q26 EBITDA as Petrochemical Utilization Rebounds

The Globe and Mail

2026-05-06

Braskem Posts Mixed 1Q26 Operational Performance as Core Petrochemical Utilization Improves but Mexico and Green PE Weaken

2026-05-06

Braskem (NYSE: BAK) details 2026 results dates and shareholder meeting

2026-05-09

Rosen Law Firm Files Securities Class Action Against Braskem S.A.

2026-05-11

Braskem Names Two New Next-Generation Tankers for Cleaner Naphtha Trade